Glassman Wealth Services Novartis Ag Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $7,566 - $8,326	82 Added 5.21%	1,655 $167,000
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $27,945 - $31,013	295 Added 23.08%	1,573 $160,000
Q2 2023 Aug 08, 2023	BUY	$92.52 - $104.91 $2,035 - $2,308	22 Added 1.75%	1,278 $128,000
Q1 2023 May 04, 2023	BUY	$80.03 - $92.81 $10,643 - $12,343	133 Added 11.84%	1,256 $115,000
Q4 2022 Feb 06, 2023	BUY	$75.55 - $92.52 $8,159 - $9,992	108 Added 10.64%	1,123 $101,000
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $8,430 - $9,860	-113 Reduced 10.02%	1,015 $77,000
Q2 2022 Aug 04, 2022	BUY	$80.52 - $93.75 $4,428 - $5,156	55 Added 5.13%	1,128 $95,000
Q1 2022 Aug 23, 2022	BUY	$80.11 - $90.62 $5,687 - $6,434	71 Added 7.09%	1,073 $94,000
Q1 2022 Apr 14, 2022	BUY	$80.11 - $90.62 $881 - $996	11 Added 1.11%	1,002 $88,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $19,845 - $21,944	249 Added 33.56%	991 $87,000
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $4,089 - $4,757	-50 Reduced 6.31%	742 $61,000
Q2 2021 Aug 04, 2021	BUY	$85.24 - $94.15 $1,449 - $1,600	17 Added 2.19%	792 $72,000
Q1 2021 May 05, 2021	SELL	$83.5 - $98.47 $5,845 - $6,892	-70 Reduced 8.28%	775 $66,000
Q4 2020 Feb 04, 2021	SELL	$78.07 - $94.43 $2,732 - $3,305	-35 Reduced 3.98%	845 $80,000
Q3 2020 Nov 09, 2020	BUY	$82.14 - $91.0 $14,128 - $15,652	172 Added 24.29%	880 $77,000
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $566 - $637	7 Added 1.0%	708 $62,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $212 - $297	-3 Reduced 0.43%	701 $58,000
Q4 2019 Feb 07, 2020	BUY	$84.35 - $95.37 $18,810 - $21,267	223 Added 46.36%	704 $67,000
Q4 2018 Feb 06, 2019	SELL	$73.66 - $82.02 $22,539 - $25,098	-306 Reduced 38.88%	481 $41,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $8,434 - $9,756	126 Added 19.06%	787 $68,000
Q2 2018 Aug 09, 2018	SELL	$64.91 - $73.36 $2,791 - $3,154	-43 Reduced 6.11%	661 $50,000
Q4 2017 Feb 06, 2018	BUY	$72.33 - $77.64 $8,173 - $8,773	113 Added 19.12%	704 $59,000
Q3 2017 Nov 13, 2017	SELL	$74.14 - $77.27 $6,895 - $7,186	-93 Reduced 13.6%	591 $51,000
Q2 2017 Aug 09, 2017	BUY	N/A	684	684 $57,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account